AstraZeneca cancer drug trial prompts investors to take options cover
June 27, 2017 at 13:04 PM EDT
* U.S. near-term put contracts outweigh call options 3.3 times
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.